Director at Regency Centers (NYSE: REG) receives 357-share stock fee grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Regency Centers director Peter Linneman reported a routine stock-based compensation transaction. On February 4, 2026, he acquired 357 shares of common stock coded as an "A" (award) transaction. These shares represent director’s fees paid in stock under Regency’s Omnibus Incentive Plan. Following this award, he beneficially owns 53,600 shares of Regency Centers common stock held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
LINNEMAN PETER
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 357 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 53,600 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Regency Centers (REG) director Peter Linneman report in this Form 4?
Director Peter Linneman reported receiving 357 shares of Regency Centers common stock on February 4, 2026. The shares were granted as stock-based director fees under the company’s Omnibus Incentive Plan, increasing his directly held beneficial ownership to 53,600 shares.
Was the Regency Centers (REG) Form 4 transaction a purchase or an award?
The Form 4 shows an “A” transaction code, indicating an award or grant, not an open-market purchase. The 357 shares of common stock represent director’s fees paid in stock under Regency’s Omnibus Incentive Plan, with no cash price per share listed.
How were the director fees paid in the latest Regency Centers (REG) Form 4?
The filing states the transaction represents director's fees paid in stock under Regency’s Omnibus Incentive Plan. Instead of cash, the director received 357 shares of common stock as compensation, which increased his directly held beneficial ownership to 53,600 shares.
Does the Regency Centers (REG) Form 4 show any derivative security transactions?
The Form 4 includes a blank derivative securities table, indicating no reported activity in options, warrants, or other derivatives for this director on February 4, 2026. The only reported transaction is the non-derivative common stock grant of 357 shares.